CClinicalTrials.gg
RecruitingNCT07130825Updated Aug 19, 2025

The Effect of Different Physical Activity Strategy on Cognitive Efficiency and Mental Fatigue Resistance

An interventional study of 8 hours simulated mental workday and Moderate intensity aerobic activity in Healthy Adults, sponsored by Lithuanian Sports University. Recruiting at 1 site in Lithuania. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-19.

Sponsored by Lithuanian Sports University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Aug 2025; still recruiting 1 year 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The main aim of this biomedical study is to determine the effect of moderate-intensity aerobic exercise, before and after an 8-hour workday and a combined work model, on the performance and efficiency of cognitive functions during mental work.

There are lack of previous studies analysing the effects of different physical activity strategies on cognitive efficiency and investigating mental fatigue resistance. Limited research in this area shows that the mechanism of the effect of physical activity on mental fatigue resistance is still unclear. This research will aim to investigate different physical activity strategies, such as combined work model and moderate intensity physical activity before and after office workday, and their impact on a mental and emotional fatigue, cognitive efficiency, sympathetic and parasympathetic systems and metabolic indicators during mentally demanding 8 h workday.

Read the detailed description

Prolonged sedentary behavior and sustained cognitive workload during typical office workdays contribute significantly to the onset of acute mental fatigue (Kunasegaran et al., 2023). This condition is linked to physiological mechanisms such as reduced cerebral blood flow, diminished glucose availability and transport to active brain regions (García et al., 2021; Kennedy \& Scholey, 2000), as well as hormonal alterations (Miyashita \& Williams, 2006; Wiehler et al., 2022). These changes negatively impact cognitive efficiency, motivation, and overall brain function (Kunasegaran et al., 2023; Tran et al., 2020). While existing evidence supports the positive influence of physical activity on physical and mental health (Calderwood et al., 2021; Jacquet et al., 2021), there remains a lack of research specifically examining how different physical activity strategies influence cognitive efficiency and resistance to mental fatigue.

This study aims to address this gap by investigating the effects of various physical activity interventions, including a combined work-exercise model and moderate-intensity aerobic exercise performed either before or after an 8-hour mentally demanding workday. Outcomes will focus on mental and emotional fatigue, cognitive efficiency, autonomic nervous system activity (sympathetic and parasympathetic balance), and metabolic responses. By evaluating these parameters, the study seeks to clarify the potential of targeted physical activity strategies to enhance mental fatigue resistance and support cognitive performance in occupational settings. The findings are expected to contribute valuable insight into the development of effective workplace interventions that promote employee well-being, productivity, and resilience.

02

Conditions studied

  • Healthy Adults
03

In context

Lead sponsor

Lithuanian Sports University is the lead sponsor of 36 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • BMI from 18.5 to 24.9 kg/ m2;
  • No chronic non-communicable diseases;
  • No mental illnesses or disorders;
  • No cancer and no chemotherapy in the last 5 years;
  • No hearing impairment;
  • No smoking;
  • No psychotropic substances;
  • Heart rate (HR) about 60 bpm at rest;
  • Unimpaired color vision;
  • Unimpaired or corrected vision;
  • Systolic blood pressure from 90 to 139 mmHg, and diastolic - from 50 to 89 mmHg at rest.

Exclusion criteria

Exclusion Criteria:

  • mental, oncological, metabolic, cardiovascular, skeletal, muscular, respiratory system disorders or diseases, impaired color vision.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Control

    Healthy young subjects will participate in research "control" condition attending 8 h simulated working day. During simulated working day subjects will perform cognitive tasks (ANAM4, version 4; Vista Life Science, Norman, OK, USA) for 8 times (1 session 11 tests about 45 min). The effect of a mental workday on cognitive function indicators will be evaluated. Same participants will participate in 3 research trials (control, aerobic activity and combined work model).

    Other: 8 hours simulated mental workday

  • Experimental
    Aerobic activity

    Healthy young subjects will participate in research "aerobic activity" condition attending 8 h simulated working day. Subjects will cycle 30 min on a veloergometer in a 50 % of maximal capacity before the cognitive tasks and after them (before and after simulated 8 h workday). During simulated working day subjects will perform cognitive tasks (ANAM4, version 4; Vista Life Science, Norman, OK, USA) for 8 times (1 session 11 tests about 45 min). The effect of a moderate-intensity aerobic physical activity before and after 8 hours of a mental workday will be evaluated. Same participants will participate in 3 research trials (control, aerobic activity and combined work model).

    Other: 8 hours simulated mental workday · Other: Moderate intensity aerobic activity

  • Experimental
    Combined work model

    Healthy young subjects will participate in research "combined work model" condition attending 8 h simulated working day. Subjects will perform cognitive tasks applying combined work model, which means that participants will be changing their positions from sitting on a balance ball to standing while performing cognitive tasks. During simulated working day subjects will perform cognitive tasks (ANAM4, version 4; Vista Life Science, Norman, OK, USA). The effect of a the combined work model on cognitive functions indicators during a simulated 8 h mental working day will be evaluated. Same participants will participate in 3 research trials (control, aerobic activity and combined work model).

    Other: 8 hours simulated mental workday · Other: Combined work model

Interventions

  • Other8 hours simulated mental workday

    During a simulated 8-hour mental work day, subjects will complete a set of cognitive tests (ANAM4, version 4; Vista Life Science, Norman, OK, USA) 8 times (1 session approximately 45 minutes), with a break of approximately 10 minutes after each session.

  • OtherModerate intensity aerobic activity

    In one of the conditions, subjects will perform moderate intensity aerobic activity (cycle veloergometer) for 30 min before 8 hours simulated mental workday and after.

  • OtherCombined work model

    In one of the conditions, subjects will perform cognitive test during 8 hours simulated mental workday applying combined work model (they will work standing and sitting on a balance ball).

06

What researchers measure

Primary outcomes

  1. Body mass and body composition (kg)

    Body mass and composition (in kilograms) will be evaluated using Tanita Body Composition Analyzer (Japan).

    Time frame: 2 times in the mornings (day 1 and day 2) of each 3 conditions.

  2. Height (m)

    Height (in meters) will be measured using a Harpenden anthropometer set (Holtain Ltd, UK).

    Time frame: 2 times in the mornings (day 1 and day 2) of each 3 conditions.

  3. Brain hemodynamic response

    To measure and evaluate hemodynamic response, a functional near-infrared (fNIRS) device NIRx NIRS Sport2 (Medical Technologies LLC-NIR-Scout, USA) with 8 near-infrared (NIR) radiation sources and 7 photodetectors will be used. The photodetectors record the relative changes in oxygen and oxygenated hemoglobin at 7.81 Hz for both wavelengths. The probes are placed at the manufacturer's specified locations to capture the hemodynamic response of the prefrontal cortex. Live recording will be monitored for 6 minutes.

    Time frame: Before, immediately after the simulated mental workday, 3 hours after the simulated mental workday, and 12 hours recovery after a simulated mental workday in 3 conditions.

  4. Cognitive performance

    Automated Neuropsychological Assessment Metrics Test Set (ANAM4, version 4; Vista Life Science, Norman, OK, USA). 11 tests will be selected, reflecting the three main cognitive functions - memory, attention and executive function. 11 tests: Procedural RT, Memory search, Spatial processing simultaneous, Matching grids, Matching to sample, Stroop colour word test, Code substitution-learning and Code substitution-delayed, Running memory continuous performance, Continous performance test - traditional. To assess cognitive performance, during a simulated 8-hour mental work day, the subjects will complete a set of cognitive tests 8 times (1 session approximately 45 minutes), after each session there will be a break of approximately 10 minutes. Participants were familiarized with the test battery twice before the experiments.

    Time frame: Day 1 in 3 different conditions, in 1 condition 8 times for 45 minutes.

  5. Blood pressure (mmHg)

    Systolic and diastolic blood pressure (in mmHg) will be measured using a blood pressure monitor (Biolight, Patient Monitor S10, Guangdong Biolight Meditech Co, Hamburg, Germany).

    Time frame: 11 times during 1 condition (total 33 times).

  6. Heart rate and heart rate variability (ms)

    Heart rate (HR) will be recorded using a heart rate monitor (Polar H10, Kempele, Finland) with an electrode strap around the chest throughout the study. 5-min RR interval file will then be analyzed using Kubios HR Variability Analysis Software 2.0 (Biomedical Signal and Medical Image Analysis Group, Department of Applied Physics, University of Kuopio, Kuopio, Finland).

    Time frame: During 1 condition rest measurements in the morning, during brain hemodynamic response (3 times during 1 condition), during every session of 8 hours simultaneous mental work day, total 3 conditions.

  7. Glucose level (mmol/l)

    Glucose level will be measured from capillary blood using Akray glucose analyzer (CONTOUR®PLUS ELITE; Basel, Switzerland). Capillary blood samples will be taken by a qualified medical professional (general practice nurse) at the LSU Institute of Sports Science and Innovation laboratory.

    Time frame: 9 times during 1 condition (total 27 times).

  8. Ketones level (mmol/L)

    Ketones level will be measured from capillary blood using a ketone analyzer (The On Call® GK Dual; San Diego, CA; USA). Capillary blood samples will be taken by a qualified medical professional (general practice nurse) at the LSU Institute of Sports Science and Innovation laboratory.

    Time frame: 9 times during 1 condition (total 27 times).

  9. Lactate level (mmol/L)

    Lactate levels will be measured using a lactate analyzer (Lactatte Pro 2, Arkray, Koji Konan-cho, Koka-shi, Japan). Capillary blood samples will be taken by a qualified medical professional (general practice nurse) at the LSU Institute of Sports Science and Innovation laboratory.

    Time frame: 9 times during 1 condition (total 27 times).

  10. Salivary cortisol concentration (µg/dl)

    The saliva samples will be collected to measure cortisol level (in µg/dl) using an ELISA kits and a Spark multimode microplate reader (Tecan, Austria).

    Time frame: 11 times during 1 condition (total 33 times).

  11. Salivary testosterone concentration (µg/dl)

    The saliva samples will be collected to measure cortisol level (in µg/dl) using an ELISA kits and a Spark multimode microplate reader (Tecan, Austria).

    Time frame: 11 times during 1 condition (total 33 times).

  12. Salivary female sex hormones concentration (pgmol/L)

    The saliva samples will be collected to measure cortisol level (in µg/dl) using an ELISA kits and a Spark multimode microplate reader (Tecan, Austria).

    Time frame: 11 times during 1 condition (total 33 times).

  13. Biochemical urine analysis

    The urine sample will be analyzed in the laboratory using a urine analyzer (PocketChem UA, PU-4010, Arkray, Koji, Konan-cho, Koka-shi, Japan). The analyzer will determine the concentrations of ketones.

    Time frame: 2 times during 1 condition (total 6 times).

  14. Pupil diameter (mm)

    The dilation and contraction of the pupils of the test subjects' eyes will be recorded using a special camera (Gazepoint, Vancouver, Canada), which will be placed under the computer screen, in front of the subject.

    Time frame: Before and 3 times during simulated 8 hours workday in 1 condition (total 12 times).

  15. The psycho-emotional state: Dundee Stress State Questionnaire (DSSQ)

    The psycho-emotional state of the subjects will be assessed using the Dundee Stress State Questionnaire (DSSQ). The DSSQ questionnaire will be used to assess the subjects' motivation in relation to the content of the task, performing a cognitive test battery during the mental work day. 15 questions will be used, e.g.: "the content of the task was interesting", "I wanted to do the task well compared to others", etc. The subject will have to mark the corresponding answers to each question, where 4 (strongly), 3 (very), 2 (a little), 1 (a little), 0 (not at all).

    Time frame: Before and 8 times during simulated 8 hours workday in 1 condition (total 27 times).

  16. The psycho-emotional state: the VAS scale

    Motivation, mental fatigue and mind wondering will be assessed using a visual analogue scale (VAS). Subjects will mark their feelings on a 10 centimetres horizontal line from 0 ("completely unmotivated"; "not mentally tired"; "no mind wandering") to 100 ("maximum motivated"; "maximum mental fatigue"; "maximum mind wandering").

    Time frame: Before and 8 times during simulated 8 hours workday in 1 condition (total 27 times).

  17. The psycho-emotional state: Stanford sleepiness scale.

    The Stanford Sleepiness Scale will be used to assess subjects' sleepiness. On this scale, subjects will mark their level of sleepiness from 1 "I feel active, efficient, lively, alert or awake" to 7 "I can no longer fight sleep, I will fall asleep quickly; thoughts are like dreams".

    Time frame: Before and 8 times during simulated 8 hours workday in 1 condition (total 27 times).

  18. Measurement of maximal aerobic capacity

    The maximal aerobic capacity of the subjects will be measured in order to determine the average aerobic load, which will be applied in the study condition "aerobic activity ". The subjects will perform a consistently increasing load until complete fatigue on a bicycle ergometer (Lode B.V., Excalibur Sport, Groningen, Netherlands). Throughout the test, subjects will have their heart rate monitored using a chest strap heart rate monitor (Polar H10, Kempele, Finland). A spirometry system (Metalyzer 3B, Cortex, Leipzig, Germany) will be used to measure oxygen uptake (VO2). VO2max (maximum oxygen uptake) will be considered the highest oxygen uptake during any 15 s of exercise.

    Time frame: Before.

  19. Sleep quality assessment

    Sleep (hours of total sleep and sleep stages) will be monitored using a Garmin wrist-worn watch (Vivo fit 4, UK).

    Time frame: 3 days before each condition and during testings.

  20. Physical activity assessment

    Physical activity (steps per day) will be monitored using a Garmin wrist-worn watch (Vivo fit 4, UK).

    Time frame: 3 days before each condition and during testings.

  21. Biochemical urine analysis

    The urine sample will be analyzed in the laboratory using a urine analyzer (PocketChem UA, PU-4010, Arkray, Koji, Konan-cho, Koka-shi, Japan). The analyzer will determine the concentrations of leukocytes.

    Time frame: 2 times during 1 condition (total 6 times).

07

Study locations

1 of 1 sites recruiting
  • Institute of Sport Science and Innovations
    Kaunas, Lithuania
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07130825
Lead sponsor
Lithuanian Sports University
Responsible party
Sponsor
First posted
Aug 19, 2025
Start date
Aug 1, 2025
Primary completion
Mar 1, 2031 (estimated)
Completion
Mar 1, 2031 (estimated)
Last update
Aug 19, 2025

Study contacts

Marius Brazaitis, professor
Contact
marius.brazaitis@lsu.lt
+37067059637
Aura Mažuolytė-Binderienė
Contact
aura.mazuolyte-binderiene@stud.lsu.lt
+37061515610

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion